about
Ligand-activated site-specific recombination in miceFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerComputational and Practical Aspects of Drug RepositioningConditional gene expression in the mouse inner ear using Cre-loxP.Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro.A predictive framework for integrating disparate genomic data types using sample-specific gene set enrichment analysis and multi-task learningRegulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancerInhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.Estrogen receptors and proliferation markers in primary and recurrent breast cancerChemoprevention of breast cancer by tamoxifen: risks and opportunities.Orally administered endoxifen is a new therapeutic agent for breast cancer.N-arylbenzamides: extremely simple scaffolds for the development of novel estrogen receptor agonists.Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer.The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.Tamoxifen-Induced Cre-loxP Recombination Is Prolonged in Pancreatic Islets of Adult MiceFrom adjuvant therapy to breast cancer prevention: BCPT and STAR.Quinone Methide Bioactivation Pathway: Contribution to Toxicity and/or Cytoprotection?Tamoxifen and the female reproductive tract.Synthesis and structure-activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution.The search for the ideal SERM.Molecular mechanisms of tamoxifen-associated endometrial cancer (Review).Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.Rapid generation of inducible mouse mutantsPotential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptorsFatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.Therapeutic potential of growth factors and their antagonists.Breast cancer medications and vision: effects of treatments for early-stage disease.Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variantsProgestins in breast cancer treatment. A review.Pharmacogenetics in the treatment of breast cancer.The development of an inducible androgen receptor knockout model in mouse to study the postmeiotic effects of androgens on germ cell development.Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.Genotoxic mechanism of tamoxifen in developing endometrial cancer.
P2860
Q24600193-0D373EE3-28FC-477B-AB87-2D89A94C94EEQ24685693-650D5110-7529-46A3-B39D-2CEAB0870A7CQ26799146-20FE0D7B-E4C3-4C7A-BC50-90BDA8706041Q26991845-556B5E1E-C283-46F6-A87F-A7BED575D2FCQ30385768-AC9E8BA1-8511-4A9F-9F5A-63EB8EFDE128Q30420135-E697A43B-0650-4A04-88BC-3D55B070F3F8Q30571667-EF9A04E2-8543-485B-9820-B99A29B23E3FQ33576459-67C2F35E-F34F-45CC-A145-DCB301887B05Q33739494-5D51FEDF-CA21-4277-B442-B642464E8094Q33777797-718388D6-50CB-4EE4-97CB-CD2950428CEFQ33909035-DC193C6A-3796-42AB-83EF-7E8FC6382E11Q33953032-C0736AF9-3DCA-4C11-A8F2-CF3A0A423A7FQ34072601-7CBE9510-D04D-4C15-906D-878BEA5D9354Q34091195-DB98E585-779E-44DB-9482-F053FA695778Q34101025-FFD86FEA-27AF-42E7-9DAB-937E849AE432Q34117974-BCF3C76A-0D74-4624-8770-4EF2D41EF50CQ34205869-77D18019-5BB8-4B93-A7D4-4F608D293143Q34217394-2122FAA3-E76E-403E-A77F-E35ED2E225CAQ34317586-FCA02B94-8158-4E34-A17F-D99CA59FA1C5Q34378297-F258E0D7-8403-4212-92EF-910B9CE51B5BQ34390342-4905095A-1822-4E8D-B370-18064FE1A8DCQ34428008-81F586D7-CDD2-475A-B257-CA1C4B793FE3Q34660744-C79091F6-6FAC-4567-AFC8-9F8D5A77B807Q34668715-360A0237-3359-4C47-A7C5-D7D91A930A33Q34736075-8AF9328E-D9BB-4B65-8DBD-946329079AEAQ34736986-6A1ACCB5-98EE-4164-867E-52141BA35313Q34771977-0365911D-6236-490B-AB87-289432119CFFQ34774040-5473F038-4ABA-41AC-920D-A3F840BBD2BEQ34914140-B0421963-7DF6-4607-ADFA-9172330182EBQ35008045-255F25C1-22AB-45C9-95A7-2DD6ABCDC80CQ35052293-E2455566-8A47-4288-BB3F-0076C5A5C88DQ35180289-D6C8C05E-0807-42DD-B84D-0762A2B2554BQ35242622-B4085B91-DBEF-45FD-A28B-016C0DE664E8Q35496778-11694C7B-E276-4C29-83C1-0D9001CFB9F6Q35605724-5D5120BB-B7F2-40F3-B9B6-B0E4AD033B14Q35651439-3564AA79-87A1-4DA5-911B-67CD740FD719Q35692680-5C5E74D2-9A58-496D-939D-E8A895CA61BEQ35733217-72080C75-7AAA-4F0A-BA92-AA5B73B0FEDBQ35786199-D47A0996-3B00-4423-8AE8-2F7F508EE6BFQ35828013-65122CEB-9DED-4535-A343-02D9AFD128B6
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականին հրատարակուած գիտական յօդուած
@hyw
1984 թվականին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
The pharmacology and clinical uses of tamoxifen
@ast
The pharmacology and clinical uses of tamoxifen
@en
The pharmacology and clinical uses of tamoxifen
@nl
type
label
The pharmacology and clinical uses of tamoxifen
@ast
The pharmacology and clinical uses of tamoxifen
@en
The pharmacology and clinical uses of tamoxifen
@nl
prefLabel
The pharmacology and clinical uses of tamoxifen
@ast
The pharmacology and clinical uses of tamoxifen
@en
The pharmacology and clinical uses of tamoxifen
@nl
P1476
The pharmacology and clinical uses of tamoxifen
@en
P2093
P304
P356
10.1016/0163-7258(84)90043-3
P407
P577
1984-01-01T00:00:00Z